The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, perso1
Service News from Hematología
The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
Anticoagulant treatment, Vitamin K and Diet
Following dietary recommendations, taking vitamin K regularly and treatment with an anticoagulant, such as Sintrom (acenocoumarol), are all important1
Leukaemia’s evolution is already written right from the start, at the time of diagnosis
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
IDIBAPS and Fundació Clínic announce the 1st Estella Matutes Extraordinary Scholarship for research in lymphoid tumors
The call for the presentation of applications for the I Estella Matutes Extraordinary Scholarship is open from September 19th to November 30th.
Can Inflammatory Bowel Disease affect other parts of the body?
Despite being closely related to the digestive system, Inflammatory Bowel Disease (IBD) can affect other parts of the body such as the joints, skin a1
A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1
Vulnerable people caring for vulnerable people
Carers from the Formació i Treball APROP job pool provide home care for people in the early stages of a bone marrow transplant. Between 2020 and 2021
Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1
AEMPS authorises Hospital Clínic's CAR-T ARI-0001 for patients with acute lymphoblastic leukaemia
The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug o1